Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28524684 | 0.97 | TSHR (0.43) | TSHRACE2 | |
| SCHEMBL20610005 | 0.84 | TSHR (0.59) | TSHRACE2 | |
| SCHEMBL102836 | 0.83 | ACE2 (0.43) | TSHRACE2 | |
| SCHEMBL1968684 | 0.83 | LMNA (0.43) | TSHRACE2 | |
| SCHEMBL1970516 | 0.83 | LMNA (0.43) | TSHRACE2 | |
| SCHEMBL1971275 | 0.83 | ACE2 (0.43) | TSHRACE2 | |
| SCHEMBL7099942 | 0.81 | ACE2 (0.42) | TSHRACE2 | |
| SCHEMBL7104794 | 0.81 | ACE2 (0.42) | TSHRACE2 | |
| SCHEMBL1109989 | 0.81 | ACE2 (0.52) | TSHRACE2 | |
| SCHEMBL3107782 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986215-A | 2-Phenyl-4-acyl benzofurans, preparation and application thereof | 中国医学科学院药物研究所 | 2024-05-07 | — | — | CN | claimed |
| CN-116693479-A | BysspinA derivative, preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-09-05 | — | — | CN | claimed |
| CN-115745987-A | Luciferase substrate and preparation method and application thereof | 华东理工大学 | 2023-03-07 | — | — | CN | claimed |
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | claimed |
| CN-101205268-B | Method for hydrogenating conjugated diene polymer and hydrogenation catalyst composition | TSRC CORP | 2010-09-29 | — | — | CN | claimed |
| CN-101829600-A | Hydrogenation catalyst composition and hydrogenation method thereof | TSRC CORP | 2010-09-15 | — | — | CN | claimed |
| CN-100564402-C | Method for hydrogenating polymer containing conjugated diene unit and hydrogenation catalyst composition thereof | TSRC CORP (CN) | 2009-12-02 | — | — | CN | claimed |
| CN-101205268-A | Method for hydrogenating conjugated diene polymer and hydrogenation catalyst composition | TSRC CORP (CN) | 2008-06-25 | — | — | CN | claimed |
| CN-100354319-C | Hydrogenation catalyst composition and method for hydrogenating conjugate diene polymer | TAIWAN RUBBER CO LTD (CN) | 2007-12-12 | — | — | CN | claimed |
| CN-101016348-A | Method for hydrogenating polymer containing conjugated diene unit and hydrogenation catalyst composition thereof | TSRC CORP (CN) | 2007-08-15 | — | — | CN | claimed |
| CN-1781955-A | Hydrogenation catalyst composition and method for hydrogenating conjugate diene polymer | TAIWAN RUBBER CO LTD (CN) | 2006-06-07 | — | — | CN | claimed |
| CN-111479819-B | Method for preparing peptide and method for treating alkali | 中外制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-117986215-A | 2-Phenyl-4-acyl benzofurans, preparation and application thereof | 中国医学科学院药物研究所 | 2024-05-07 | — | — | CN | disclosed |
| US-11976085-B2 | Process for producing ruthenium complexes and intermediates thereof and their use in olefin metathesis | Aperion Synthesis S.A. (PL) | 2024-05-07 | — | — | US | disclosed |
| WO-2024052871-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2024-03-14 | — | — | WO | disclosed |
| EP-0889057-B1 | Process for hydrogenating conjugated diene polymer | ASAHI CHEMICAL IND (JP) | 2003-01-08 | — | — | EP | disclosed |
| US-5886108-A | Process for hydrogenating conjugated diene polymer | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0889057-A1 | Process for hydrogenating conjugated diene polymer | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0693284-A1 | PROSTACYCLIN-CONTAINING OLEAGINOUS OINTMENT | TEIJIN LIMITED (JP) | 1996-01-24 | — | — | EP | disclosed |
| US-4549992-A | Antihypertensive amides | USV PHARMACEUTICAL CORP. (US) | 1985-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11976085-B2 | Process for producing ruthenium complexes and intermediates thereof and their use in olefin metathesis | POR, CYP1B1, CYP4F11 | TSHR 4724/4885ACE2 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.